Suzhou Zelgen Biopharmaceuticals Co.,ltd

This study is testing whether an oral medication called jaktinib can help control moderate to severe atopic dermatitis, a form of eczema. It will compare the drug to a placebo in 443 adults to see if it significantly improves skin symptoms and is safe. The goal is to provide a ne…

This Phase 3 trial is testing whether a twice-daily pill called Jaktinib can better control the painful inflammation and stiffness of active ankylosing spondylitis compared to a placebo. It involves about 265 adults whose current treatments aren't working well enough. Participant…